Efficacy and Safety of Sacubitril/Allisartan for the Treatment of Primary Hypertension

Authors

Institutions

Publication Details

Journal
JACC Asia
Published
2024-08-13
DOI
https://doi.org/10.1016/j.jacasi.2024.06.002
Citations
5
Primary Topic
Blood Pressure and Hypertension Studies
Type
article
Field-Weighted Citation Impact
2.01

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and Safety of Sacubitril/Allisartan for the Treatment of Primary Hypertension

Shao-Xing Chen, Jin Zhang, Jing-Chao Sun, Ji‐Guang Wang et al.
5 citations
JACC Asia
Blood Pressure and Hypertension Studies
2.01
article

Efficacy and Safety of Sacubitril/Allisartan for the Treatment of Primary Hypertension

Shao-Xing Chen, Jin Zhang, Jing-Chao Sun, Ji‐Guang Wang, Zichen Liu, Jinfeng Li, Qiang Wang, Yan Li, Wenjie Xu, Qian Ge, Xiangnan Zhou, Xiaohong Lu, Jie Yan, Wei Zhang
article en
5 citations

Abstract

No abstract available for this paper.
JACC AsiaVol. 4(9)
Shanghai Jiao Tong University (CN), Ruijin Hospital (CN), Shenzhen Metro (China) (CN), Shanghai Institute of Hypertension (CN)
National Natural Science Foundation of China, Shanghai Jiao Tong University, Servier, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University
Good health and well-being
Openalex Percentile: Top 12%
Blood Pressure and Hypertension Studies
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and Safety of Sacubitril/Allisartan for the Treatment of Primary Hypertension — Shao-Xing Chen, Jin Zhang, et al. · JACC Asia (2024) | TGRS Research Map | TGRS